🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchPhase 3 trial enrollment guide — my results so far Page 5

Phase 3 trial enrollment guide — my results so far

josh_phd_bmore Mon, Feb 23, 2026 at 12:22 PM 21 replies 1,019 viewsPage 5 of 5
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Mar 1, 2026 at 1:48 AM#21
lucas_SP_BR said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

That is correct as far as it goes, and here is where it stops going. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

Last edited: Mar 1, 2026 at 2:48 AM
50 0RunnerRach, TrialNerd_Beth, HPLC_Greg and 47 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Mar 2, 2026 at 2:42 AM#22
lucas_SP_BR said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

49 24PurityPaulOR, MaxMetOK, MounjBrad and 46 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Mar 3, 2026 at 3:37 AM#23

From the other side of the consultation, briefly. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

48 23cory_ATX, lori_vegas, Dr.PulmRoch and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Mar 4, 2026 at 4:33 AM#24
Dr.LipidDallas said:
Worth answering the question that was asked rather than the one behind it.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

Last edited: Mar 4, 2026 at 6:33 AM
47 22JenPlateau, SallyK_inj, CryptoCarl and 44 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Mar 5, 2026 at 5:29 AM#25
Dr.LipidDallas said:
Worth answering the question that was asked rather than the one behind it.

There is a second half to this that has not been said yet. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

46 21mike_nyc, VendorMark, COA_Karl and 43 others
Reply Quote Save Share Report
1345

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register